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CHAPTER I 
INTRODUCTION 
The leading "cause of mortality today continues to be 
cardiovascular disease despite the knowledge of risk factors (Fardy, 
1988, p. 4). Risk factors of increased cardiovascular disease 
include several preventable factors. The risk factors that can be 
modified are diet, exercise, stress levels, smoking, and knowledge 
of treatment programs/health status (Fardy, 1988). Cardiac 
rehabilitation programs incorporate exercise, diet, education, 
medications, life-style changes, and support systems for people in 
need of this service. Medications are a major portion of any 
program and the need for the patient to understand the medications 
is vital. Cardiac medications are administered for various reasons 
and may have lethal side-effects if not administered 
according to physician prescription. , 
The Problem 
Certain cardiac medications contain potentially life 
threatening side effects if taken improperly. Safe administration 
of potentially dangerous medications is crucial for the cardiac 
patient at home. The most reasonable method to ensure safety with 
cardiac drugs is through an educational program. This program would 
be completed prior to discharge from the hospital. Patients' 
knowledge of cardiac medication regime at the time of hospital 
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discharge from Stillwater Medical Center is unknown at this time. 
The Purpose 
The purpose of this study is to determine the patients 
knowledge of their cardiac medication regime with and without 
individualized educational program provided to patients regarding 
cardiac medication prior to hospital discharge. 
Hypothesis 
2 
There will be no significant difference between the patients' 
knowledge of their cardiac medication regime upon hospital discharge 
between those patients that received an individualied educational 
program and those that did not. 
Definition of Terms 
The following definition of terms were used throughout this 
study. 
Adrenergic Receptor Blocking Agents - Selectively inhibits 
sympathetic response of certain tissue (cardiac) and results in 
decreased blood pressure. Catapress, Tenornum, Inderal, Lopressor, 
and Lanoxin will be grouped together in this study (Thomas, 1984). 
Beta Adrenergic Blocking Agents - A substance that interferes 
with the transmission of stimuli through pathways that normally 
allow sympathetic nervous inhibiting stimuli to be effective 
(Thomas, 1985). 
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Calcium Channel Blocking Agents - Inhibits the calcium exchange 
within the cardiac cell and slows the conduction through the heart. 
The result is a slower heart rate. Calan and Cardizem will be the 
medications used within this group of drugs (Thomas, 1985). 
Cardiac Medications - Those medications that a patient is 
taking and produces a direct or indirect effect upon the Inotropic 
or Chrontrophic activity of the cardiac tissue. Medications that 
effect the circulation blood volume or effect the vascular system 
will also be included. 
For the purpose of this study, the medications will be limited 
to the following categories: Beta Blocking Agents, Diuretics, 
Calcium Channel Blocking Agents, and Nitrates. 
Cardiac Monitoring - A computerized machine that transmits the 
electrical activity of the cardiac muscle (heart) into an observable 
wave form that can be evaluated by specially trained personnel 
(Fardy, 1988). 
Cardiac Rehabilitation Program Phase 1 - An inpatient program 
that includes patient and family education and exercise programs that 
are designed to prevent complications from bedrest (Fardy, 1988). 
Cardiac Nurse Educator - A specialized nurse with experience in 
cardiac and emergency nursing. This nurse will educate the 
patient/family accordingly to prescribed therapy and medications 
(Fardy, 1988). 
care Giver - One who outlines the activities on a daily basis. 
The care giver ensures completion of the following items daily: bath, 
general housekeeping, administration of medications, preparation of 
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meals, and intervenes with problems throughout the day. 
Chrontrophic - Medications which act upon the cardiac tissue to 
change the rate of the heart beat (Thomas, 1985). 
Diuretic - A drug that promotes renal excretion of electrolytes 
and water, thereby increasing urine volume. Lasix and Bumex will be 
grouped together under this category of medications (Thomas, 1985). 
High Risk Patient - A patient that is at high risk for having a 
myocardial infarction during exercise programs (Fardy, 1988). 
Individualized Educational Program - The manner in which 
selected information regarding cardiac medication was presented to 
an individual patient and/or family. 
Inotropic - Medications which act upon the cardiac tissue to 
change the force of the cardiac muscle contraction (Thomas, 1985). 
Nitrate - A drug that relaxes vascular smooth muscles, 
especially for the purpose of improving peripheral or coronary blood 
flow (Thomas, 1985). 
Palpitation - An unusual awareness of one's heart pattern 
within the chest cavity. An irregular, rapid throbbing or 
fluttering of the heart (Thomas, 1985). 
Sympathetic Nervous System - A part of the autonomic nervous 
system (thoracolumbar) in which nerves leave the central nervous 
system to synapse with other nerve fibers close to the spinal cord. 
Frequently referred to as the flight or fight aspect of the nervous 
system (Thomas, 1985). 
Vasodilator - A medication which acts upon the smooth muscle 
tissue (blood vessels) in such a manner that dilates the lumen of 
the vessel. Apresoline, Capoten, and Nitroglycerin will be grouped 
under this classification of medications (Thomas, 1985). 
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CHAPTER II 
REVIEW OF LITERATURE 
Introduction 
The problem in which this study was concerned regarded the 
knowledge of patient discharge understanding of cardiac medications. 
The review of literature was used to develop a baseline of knowledge 
regarding the role of cardiac rehabilitation programs and nurse 
educators. 
The review of literature concentrated on four areas. First, a 
history of cardiac rehabilitation programs and the impact upon 
today•s practice. This will explore both the emotibnal and the 
physical indications for a cardiac rehabilitation program. 
Second, the role of specific cardiac medications will be 
reviewed. Since the patients' knowledge of their cardiac 
medications was the focus of this study, it was necessary to 
establish a clear understanding of the importance of patient's 
knowledge regarding medications. 
Third, the role of the nurse as an educator will be explored. 
This is one of several roles that a registered nurse (RN) at 
Stillwater Medical Center is utilized for. 
Finally, the fourth section of this review of literature was a 
review of related research topics. Several research projects were 
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conducted that were both directly and indirectly related to this 
topic. 
To summarize, the review of literatur.e was separated into four 
sections: (1) A review of car-diac rehabilitation programs; 
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(2) Explanation of specific cardiac medications; (3) The role of the 
nurse as an educator; (4) Exploration of directly and indirectly 
related research. 
A Review of Cardiac Rehabilitation 
Programs 
Each year more than one million American survive a myocardial 
infarct~on (MI) and approximately 230,000 persons undergo some type 
of cardiac surgery (Gulanick, 1991). These-are the two major 
implications for a rehabilitation program. The purpose of a cardiac 
rehabilitation program is to assist a cardiac patient as much as 
possible in returning to pre-injury state of functioning. There are 
two monitored phases of a cardiac rehabilitation program. Phase I 
begins when the physician has released the patient from 
classification of unstable. During this phase the goal is to 
prevent any completion of bedrest. Education to the family begins 
while the patient slowly begins ambulation and other low level 
exercises. 
Phase II of the program begins after Phase I, and when the 
patient is stable enough to be monitored (cardiac) while exercising. 
This activity is ordered by a physician just the same as Phase I. 
There are several goals of this phase, and they are as follows: 
enhance cardiovascular functioning, detect lethal arhythmias and 
other EKG changes, educate patients regarding affect and assist 
patient with the return to their working environment (Fardy, 1988). 
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The cardiac rehabilitation program will hopefully reduce the 
number of occurrences of MI's in the high-risk cardiac population 
and also decrease the number of repeat myocardial infarctions. This 
will in return decrease the death rate of recurrent MI patients 
(Blocker, 1983). 
There are contraindications for specific patients to enter a 
cardiac rehabilitation program. Although they are present, the risk 
of participation within a medically supervised cardiac 
rehabilitation program is low (Oldridge, 1991). 
When "cardiac disease occurs, there is not only a 
physiological disturbance but also a disturbance of the 
psychological and sociological components of a person's life" 
(Coston, 1960, p. 178). Both Phase I and II include this aspect 
when dealing with the patient and family. 
Maslow (cited in Burns, 1965, p. 73) postulates that "each of 
us has an essential inner nature that includes needs he called 
'instinctiod'". This is believed to be a remnant of our basic 
instinct which sets our potential for growth and behavior changing 
abilities. This is the basis for our motivations from which we 
change ourselves into a naturally more healthy person. 
The educational aspect of cardiac rehabilitation programs tap 
in on behavior modification through educational programs and the 
support of family and other participants (Kappagoda, 1984 and Ford, 
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1976). "The significant relationships identified between individual 
beliefs and values provide a beginning understanding of variables 
that influence wellness motivation in cardiac 
rehabilitation" (Derenowski, 1991, p. 6). 
Cardiac Medications 
Cardiac medications are used as an integral treatment measure 
to stabilize and maintain the cardiac patient after initial cardiac 
assault. The following groups of medications will be discussed: 
adrenergic-blocking agents, calcium channel blocking agents, 
nitrates and vasodilator, and diuretics. 
Two types of receptors present within the body are alpha-
adrenergic and beta-adrenergic receptors. First, the alpha-
adrenergic receptors will be discussed in relationship to the 
medication that place their effect upon these receptors, the results 
produced within the body, and unwanted side effects. 
Adrenergic blocking medications reduce sympathetic responses 
either at the receptor site or at the adrenergic nerve level. 
Alpha-adrenergic blocking medications work at the receptor site and 
prevents sympathetic hormones from stimulating the cell. This 
results in a reduction of vasoconstriction. Due to this response 
within the body, those on this medication may experience 
hypotension, dizziness when changing positions, increased heart 
rate, palpation, cardiac arrhythmia, and chest pain (Spencer, 1983). 
The beta-adrenergic receptors primarily are directed toward the 
force of a muscle contraction. The beta-adrenergic blocking 
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medications work in specific muscle tissue. The cardiac beta-
adrenergic blocking agents work upon the cardiac muscle by 
selectively inhibiting the sympathetic response which produces a 
lower blood pressure by the decrease in cardiac contractility. The 
most serious side effects of these types of medications are 
congestive heart failure in one who has severe cardiac compromise 
and possible cardiac arrest. other untoward side-effects include 
the following: increased airway resistance, atrial-ventricular heart 
blocks, nausea, vomiting, and constipation. With abrupt withdrawal, 
acute hypertensive episodes may result (Spencer, 1983). 
Medications that effects the rate of electrolyte exchange also 
have effects upon the cardiac muscle as well as other muscle 
tissues. Calcium Channel Blocking medications those that have a 
short duration because they "inhibit the influx of calcium ions 
through slow channels into contractile and conductive myocardial 
cells and vascular smooth muscle cells" (Govoni and Hayes, 1985, p. 
1269). This action also blocks the internal store of calcium which 
creates an end result of slowing the electrical conduction of the 
cardiac tissue. The slowing of cardiac electrical conduction with 
the cells results in a slower heart rate. Some peripheral 
vasodilation may also result. As a result of the effects upon the 
body by calcium channel, blocking medications, the following may be 
seen as side-effects: severe hypotension, cardiogenic shock, atrial-
ventricular block, congestive heart failure, and cardiomegaly 
(Govoni and Hayes, 1985). 
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Another classification of cardiac medications are the 
diuretics. This group of medications work by decreasing the 
circulating blood volume. This decrease in volume is accomplished 
by increasing the production of urine by effects placed upon the 
kidney. The kidney will respond to medications that effect the 
glomerular filtration rate, tubular reabsorption, and the tubular 
secretion. Different diuretics will effect one of these areas 
within the kidney and reduce circulating blood volume. Dehydration, 
hypovolemia, nausea, vomiting, electrolyte depletion, hypokelemia, 
and metabolic acidosis may result if too much flood and/or 
electrolytes are excreted (Spencer, 1983). 
Vasodilators are a group of medications that relax the smooth 
muscle of the blood vessel throughout the body by influencing the 
nervous and endocrine system. This system can be altered by 
medications that effect any portion of the nervous or endocrine 
system which extends from the Asdrenal Medulla through the spinal 
cord to the smooth muscle in the vessel itself. Although this is 
uncommon, excessive vasodilation may result in neurogenic shock. 
More common side-effects are headache, hypotension, dizziness, 
weakness, and fainting. 
The Nurse as an Educator 
One of the major roles a nurse may play is that of the nurse 
educator. Patients view the visits by nurses as very important and 
remember the content of their visits in detail (Bolodar, 1979). 
In order for an effective educational session to begin, the 
nurse must first consider the patients' perspective. This is 
accomplished by utilizing a self-care assessment instrument which 
can then be used to individualize the educational session 
(Johannsen, 1992). When done in this manner, the cardiac patient 
receives the information he/she needs, and unnecessary information 
is eliminated. 
Nurses must be skilled in the area of cardiac nursing and 
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must contain flexibility for adapting diplomatically to various 
situations that she/he may be placed. The nurse needs to be 
respected by co-workers in order for the patient and family to see 
validity in the information provided. The educator will earn the 
respect of the patient and family when they feel he/she is reliable 
(Burns, 1991). 
Previous research studies have shown the impact that staff 
personalities have upon the compliance of cardiac rehabilitation 
programs. Oldridge (1984) researched the compliance and dropout in 
cardiac exercise rehabilitation programs. He found that the 
impersonal and unreceptive staff members played a significant role 
in dropout rates. 
Related Research 
The Scottish are known to have one of the highest rates of 
deaths from coronary heart disease in the world (Newton, 1991). 
Newton examined the costs of coronary (artery) disease (CAD) in 
human and economic terms. The conclusions drawn from Newton's 
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research indicated prevention and rehabilitation of the cardiac 
population to be of paramount importance. Newton (1991) researched 
the effects of exercise in a cardiac rehabilitation program and 
discovered that the psychological functioning of participants were 
statistically improved from the control group. This study included 
22 male and female patients post myocardial infarction during a ten-
week exercise based program. 
Cardiac rehabilitation programs also may be used for patients 
at high risk for developing further cardiac complications. Theroux 
(1979) explored the area of a prognostic value of exercise testing 
post myocardial infarction. He concluded that the results of an 
exercise cardiac testing are indeed a safe and reliable source of 
mortality prediction in the post MI person. 
The study that is most related to this project was conducted by 
Sister Patricia Miller (1990) on the compliance of cardiac program 
regime. She found no differences between experimental and control 
groups for regimen compliance to activity, stress, and medication 
prescriptions. The experimental group was significantly more 
compliant to the diet prescription than the control group. 
Surprisingly, the control group was significantly more compliant 
than the experimental group with cessation from smoking. It was 
thought, at the time of this study that the medication compliance 
varied little due to patient beliefs This study suggests that these 
subjects correlated medications with survival; therefore, little 
information was required to attain the compliance of participants. 
CHAPTER III 
METHODOLOGY 
The purpose of this study was to compare patients' 
understanding regarding significant aspect of their cardiac 
medication regime with and without an individualized educational 
program provided. In order to accomplish this task, it was 
necessary to obtain the knowledge of patients regarding their 
understanding of prescribed cardiac medications with and without an 
individualized program presented. 
To accomplish the purpose of this study, the methodology was 
organized according to the following outline. 
1. Identify the population and identify frequently used 
cardiac medications. 
2. Develop the questionnaire for patients. 
3. Develop the information sheet regarding specific 
medications that patients will receive. 
4. Develop educational program. 
5. Administer the questionnaire to the control group and then 
to the experimental group. 
6. Compare the survey results. 
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Population and Cardiac Medication 
Identification 
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The population was defined as those patients who were 
discharged from the hospital and receiving a prescribed cardiac 
medication during that hospitalization. There were no age limits 
placed upon the population; however, the population excluded those 
who would return or be admitted to a nursing home. If the patient 
had a disability that rendered them incapable of learning 
information regarding cardiac medications, the care giver was given 
the questionnaire. Those patients utilizing home-care nursing staff 
were excluded from the survey. The population was defined also by 
the time frame of discharge dates between August 1, 1992 and October 
21, 1992. 
The medical staff and hospital administration was required to 
approve this project pr~or to initiation of the study. This was 
completed in July, 1992. 
Medications were identified by a survey to determine the most 
commonly used cardiac medications at Stillwater Medical Center with 
potentially lethal side-effects. This was accomplished by reviewing 
ten charts per week on a sporadic basis and tallying medications 
being administered. These medications were then researched through 
the Physicians Desk Reference book indicating a potential for lethal 
side effects. The medications chosen to focus upon were as follows: 
Apresoline, Capoten, Nitrogylcerin, Bumex, Lasix, Calan, Cardizem, 
Tenornum, Catapres, Inderal, Lopressor, and Lanoxin. 
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Development of Questionnaire 
The questionnaire was designed to facilitate the collection of 
information from those patients or patient care givers regarding 
knowledge of prescribed cardiac medications. The instrument was 
designed to provide information that would answer the following 
research questions is there a significant difference between the 
patients' knowledge of their cardiac medication regime at the time 
of hospital discharge with and without an individualized educational 
program. Sample questionnaires can be found in Appendix A. A 
questionnaire was designed for each group of cardiac medications 
(adrenergic blocking medications, calcium channel blocking 
medications, diuretics, and vasodilators) to focus upon the 
important knowledge needed to administer the medication safely. 
The questionnaire was reviewed for content validity by Elaine 
Ackerson, RN, BSN, ICU/ER Nurse Manager and Dr. Ward Hardin, M.D., 
Chairman of Medicine Services. The researcher's committee reviewed 
the form for face validity. Based upon recommendations made by the 
reviewers, numerous adjustments were made to the instrument. 
A cover letter and consent form accompanied the survey. An 
example of this letter is contained in Appendix B. This letter 
explained the purpose of the survey and gave directions for 
replying. A white blank envelope was provided so that the surveys 
could be returned to the researcher within the hospital without 
patient identification. 
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Information Sheet Development 
Each medication that was identified as a frequently 
administered medication and contained the possibility of serious 
side-effects was thoroughly researched. The Physicians Desk 
Reference Book was the primary source as well as other pharmacology 
books and drug inserts for specific medication. This information 
was compiled and presented in such a manner that the general 
population could understand information given. The medications were 
listed along with generic names, the rationale for usage of 
medication, the action of the medication, and recommendations for 
safe administration of medication. 
These medication sheets were then reviewed by the following 
Stillwater Medical Center staff: Pat Lawson, RNC, BSN, Vice 
President of Patient Care Services; Elaine Ackerson, RN, BSN, Nurse 
Manager of ICR/ER; and Dr. Ward Hardin, Chairman of Internal 
Medicine. The appropriate changes were made and approved by the 
administrative staff in August of 1992. These medication 
information sheets were also given to friends outside the medical 
community to ensure that the information was presented in lay 
terminology. 
Individualized Educational Program 
The educational program varied greatly in duration. The length 
of each session depended upon the wellness and stamina of the 
patient each day individually. The individual sessions greatly 
varied in duration depending upon the number of prescribed cardiac 
medications. The number of days for program participation varied 
upon the length of hospitalization. 
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The educational program was provided to patients and care 
givers in t~e privacy of their room. Scheduling of following 
sessions occurred to accommodate other family members when possible. 
Every- attempt was made to provide a non-threatening environment to 
allow a patient the freedom for learning. 
The first program day consisted of an introduction of the 
researcher and study. A baseline assessment was obtained during 
this initial stage. A baseline assessment regarding knowledge 
included addressing the patients' and/or care givers• individual 
level of understanding. The assessment period was also a time to 
evaluate for accuracy of medication knowledge and a time to plan for 
educational adjustments, if indicated, prior to discharge. 
All patient medication administration records (MAR's) were 
reviewed daily to identify any newly prescribed cardiac medications. 
If a cardiac medication was new to a patient, the educational 
program for the new medication was initiated at that time. 
This allowed the patient to verbalize the presence of any knowledge 
regarding the medication. Dosage changes were also noted for the 
patients information. 
Information sheets were developed to accompany a specific 
cardiac medication. When a patient was prescribed one of the 
cardiac medications followed in this study, they were given the 
information sheet regarding that medication. There was no limit 
placed upon the number of cardiac medications administered to a 
patient. 
The appropriate information sheet was distributed to the 
patients and briefly reviewed. This time was utilized to begin 
instruction of recommendations if a skill (i.e. determining heart 
rate per minute) was included as a recommendation. 
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The information sheet was left with the patient to review and 
look at prior to taking the medication. Patients were encouraged to 
review the information sheet daily, in addition to the educational 
session. Patients were encouraged to participate in their care of 
medication administration actively. An example of participation was 
demonstrated by the patient who determined their heart rate prior to 
swallowing the medication. 
The second session began with questions or concerns from the 
patient regarding the prescribed cardiac medications. The questions 
were answered utilizing the information present on the medication 
information sheet. Questions that the researcher was unable to 
answer were conveyed to the physician. A message regarding the 
specific question was placed on the patient chart for the physician 
to view. The nurse caring for the patient was also notified of the 
questions or concerns to ensure physician notification. 
The information sheet was reviewed in detail with the patient 
and/or care giver. The actual pill was present in the room while 
the session occurred. 'This allowed the patient to identify the 
color, size, and shape of discussed medication from other 
medications that may also be administered. 
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Patients were visited on a daily basis at various hours of the 
day. Visits occurred daily between 9:00 a. m. and 9:00 p. m. until 
discharged. Each day the information sheet and skills were reviewed 
in detail as necessary. A portion of every session included an 
opportunity for questions and concerns to be addressed from the 
patient. Follow-up on any previous questions or concerns were also 
addressed. 
The information was explained in detail until the patient 
learned the information. Information was considered learned when 
the patient or care giver verbally stated the recommendations 
without the information sheet present. Once the information was 
learned, the recommendations wer~ reviewed daily. 
The patient who knew portions of the information, received in 
detail the recommendations that were unfamiliar. The 
recommendations that were learned were reviewed daily. The skills 
were reviewed daily as deemed necessary by the researcher. 
Each patient was provided the opportunity for input into the 
educational process. The patient's input regarding his/her learning 
styles were emphasized throughout the program. Some patients 
preferred visual learning such as visualizing the medication and the 
utilization of posters to illustrate the cardiac system. Some 
patients preferred the information sheet and desired nothing more. 
Sampling of Control Group 
A multi-step process was utilized to gather the information 
necessary to test the null hypothesis. The questionnaire was given 
21 
to inpatients that were prescribed cardiac medications at Stillwater 
Medical Center at the time of their discharge from the hospital. 
Consent was first obtained through utilization of a consent form 
(See Appendix C). 
The control group (N=Sl) consisted of those patients within the 
population discharged between August l, 1992 and September l, 1992. 
The control group was given the questionnaire without deviation from 
present discharge information. Those patients that failed to 
complete the questionnaire were followed with a telephone survey to 
acquire results. 
Patients on cardiac medications discharged after this time 
period received an individualized educational session regarding 
specific cardiac medications prescribed during hospitalization. 
They were given the information sheet during these educational 
sessions. There was no time restrictions placed upon the individual 
educational sessions due to various levels of learning. 
The individualized educational program was instituted on 
September l, 1992 and continued through October 21, 1992. The 
experimental group (N=92) are those patients on cardiac medications 
discharged between September 20, 1992 and October 21, 1992. This 
group of participants were given the questionnaire at the time of 
hospital discharge. Patients were followed with a telephone survey 
if they were discharged prior to completion of the survey. The 
experimental group was exposed to the individualized educational 
sessions regarding prescribed cardiac medications prior to hospital 
discharge. 
Comparison of Results to 
Control Group 
22 
A parametric statistical procedure was utilized to compare 
results of the control group to the experimental group. Analysis of 
variance was the statistics of choice to determine the significance 
of the educational program. Analysis of variance is a procedure for 
testing the effect of a treatment on different groups on "comparing 
the variability between groups to the variability within groups" 
(Polit, 1983, p. 609). 
After examining and analyzing the data with descriptive 
statistics, frequency counts, and means, an analysis of variance 
using fitting constants was constructed. The level of significant 
differences between the groups at the 0.05 level was chosen. Siegle 
(1956) indicated that hypothesis under test is usually that the two 
groups differ with respect to some characteristic and, therefore, 
with respect to the relative frequency with which group members fall 
into several categories. 
The data from the control and experimental group was analyzed 
to determine if differences in correct and incorrect responses were 
significant. The analysis of variance using fitting constants was 
used to determine if the differences observed were significant at 
the 0.05 level. The analysis of variance test was explained by 
Finlay (1984) as a statistical technique which may be utilized to 
test the relationship between the mean of an interval variable and 
the levels of categorical variables that is of nominal measurement. 
The analysis of variance allows the comparison of two or more means 
to see if there are significant differences between or among them 
(Bartz, 1988). The analysis will yield a numerical value large 
enough to be interpreted as statistically significant (Agresti, 
1986). In this case, it was decided that the p value must be 0.05 
or less to indicate statistical significance. 
23 
Fitting constants were utilized in the analysis of variance to 
compensate for the unequal population size in each of the 
categories. This is a method for "understanding the effects of two 
or more independent variables on a dependent measure" (Polit, 1983, 
p. 533). This step was to adjust for the independent variables of 
population size. Fitting constants are a form of regression 
analysis (Agresti, 1986). Which is a procedure for predicting 
values of a dependent variable based on the values of one or more 
independent variables (Polit, 1983, p. 62). 
Once the results of both surveys had been compiled and analyzed 
by the analysis of variance using fitting constants, the noted 
educational needs were identified. The purpose of this step was to 
validate the concerns of the nursing staff regarding the 
effectiveness of current discharge planning regarding cardiac 
medications. It would also allow the researcher to draw conclusions 
regarding the effectiveness of individualized educational sessions 
on cardiac medications that patients were prescribed. 
CHAPTER IV 
RESULTS OF THE STUDY 
The results of this study were to determine the patients' 
knowledge of their cardiac. medication regime with and without 
specific educational information provided. 
The findings of this study will be reported by correct response 
among the four medication categories in the following format: 
1. The comparison of patient's correct responses regarding 
adrenergic blocking medications with and without an educational 
program. 
2. The comparison of patient's correct responses regarding 
calcium channel blocking medications with and without an educational 
program. 
3. The comparison of patient's correct responses regarding 
diuretic medications with and without an educational program. 
4. The comparison of patient's correct responses regarding 
vasodilator medications with and without an educational program. 
Analysis of Data 
To determine the effects of an educational process upon the 
correct responses of those patients being administered an adrenergic 
blocking medication, an analysis of variance using fitting constants 
was constructed. This method was chosen to compensate for the 
varying number of participants in the population. There was a 
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possibility of six correct answers among the questionnaire on 
adrenergic blocking medications (See Appendix B for the 
questionnaire). 
Table I illustrates the mean average of correct responses 
between male and female participants. The male (N=l4) respondents 
had an average of 3.8571 correct responses compared to the female 
(N=36) average correct was 4.0833 of the six possible responses. 
The table also displays the average correct response from the 
control group (N=20) to be 2.8500. The experimental group 
(N=30) was observed to respond on an average to 4.8000 of the six 
responses correctly. 
25 
The relationship of gender to group is illustrated in Table I 
as well as in Figure 1. The experimental group increased in average 
number of correct responses from the control group in both the male 
and female responses. The averaged correct male response increased 
from 2.400 in the control group to 4.6666 of the six responses in 
the experimental group. The female responses increased from 3.000 
correct responses in the control group to 4.8571 of the six 
responses in the experimental group. 
Table II illustrates the analysis of variance of the correct 
responses related to gender and group. With a df=l, the analysis of 
variance must have a p < 0.05 to be significant at the chosen 0.05 
level of significance. A significant difference (p < 0.05) was 
found between the male and female average correct responses. This 
averaged both the control and experimental correct responses 
together for the male group and female group. The correct results 
TABLE I 
MEAN RESPONSES FROM PATIENTS RECEIVING 
ADRENERGIC BLOCKING MEDICATIONS 
category N Mean 
Correct Responses 
Gender 
Male 14 3.8571 
Female 36 4.0833 
Intervention Status 
Control Group 20 2.8500 
Experimental Group 30 4.8000 
Relationship of Gender 
and Intervention 
Male/Control 5 2.4000 
Male/Experimental 9 4.6666 
Female/Control 15 3.0000 
Female/Experimental 21 4.8571 
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TABLE II 
ANALYSIS OF VARIANCE OF PATIENT RESPONSES TO 
ADRENERGIC BLOCKING MEDICATIONS 
Source DF Sum of Mean F 
Squares Square Value 
Sex 1 1.4689 1.4689 4.91 
Intervention 1 39.9763 39.9763 133.53 
Sex + 
Intervention 1 0.3942 0.3942 1.32 
Error 46 13.7714 0.2994 
Corrected Total 49 60.9800 
N = 50 
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Pr > F 
0.0317 
0.0317 
0.2571 
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Receiving an Adrenergic Blocking Medication 
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from the experimental group were significantly higher statistically 
(p < 0.05), then the control group. There was no significant 
difference (p >= 0.05) found between the male and female responses 
in the control group and the male and female responses in the 
experimental group. 
To determine the effects of the educational process upon the 
correct responses of those patients being administered a calcium 
channel blocking medication, an analysis of variance using fitting 
constants was constructed. There was a possibility of five correct 
responses on the survey form. 
Table III demonstrates the mean average of correct responses 
between male and female participants. The male (N=ll) respondents 
had an average of 4.1818 correct responses compared to the female 
(N=20) 3.7500 responses of the five possible responses. The control 
group (N=l6) exhibited a 3.3125 correct response rate compared to 
the 4.5333 correct response rate of the experimental group (N=l5). 
The relationship between the male and female correct responses 
in the control group to the male and female correct responses in the 
experimental group was also examined. Table III illustrates this 
relationship. The male and female experimental groups increased an 
average number of correct responses. The male responses increased 
from an average of 4.0000 (N=6) correct responses in the control 
group to 4.4000 (N=5) correct responses in the experimental group. 
The female data displays an increase from 2.9000 (N=lO) correct 
responses to a 4.6000 (N=lO) correct responses in the experimental 
TABLE III 
MEAN RESPONSES FROM PATIENTS RECEIVING 
CALCIUM CHANNEL BLOCKING MEDICATIONS 
Category N Mean 
Correct Responses 
Gender 
Male ll 4.1818 
Female 20 3.7500 
Intervention Status 
Control Group 16 3.3125 
Experimental Group 15 4.5333 
Relationship of Gender 
and Intervention 
Male/Control 6 4.0000 
Male/Experimental 5 4.4000 
Female/Control 10 2.9000 
Female/Experimental 10 4.6000 
30 
group. The increase in average mean correct response of males and 
females in the control and experimental groups are exhibited in 
Figure 2. 
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Table IV displays the analysis of variance for the correct 
responses among patients receiving calcium channel blocking 
medication. There were no significant differences (p > 0.05) 
between the male and female correct responses. A significant 
difference (p < 0.05) was present between the control and 
experimental groups. The difference in correct responses between 
the males and females in the control group and the males and females 
in the experimental groups were found to be significant (p < 0.05). 
Table V illustrates the average of correct responses between 
male and female respondents receiving a nitrate medication. The 
male respondents (N=26) had an average of 3.8462 correct answers 
compared to the female (N=lS) average correct response of 3.6000 
correct answers. The table also displays the mean correct response 
from the control group (N=lS) of 2.7333 while the experimental group 
(N=26) was observed to respond to 4.3462 of the five responses 
correctly. 
The relationship of gender to group is illustrated in Table V 
as well as in Figure 3. The experimental group increased in average 
number of correct responses. The average correct male response 
increased from 3.0909 in the control group to 4.400 of the six 
responses in the experimental group. The female responses increased 
from 1.7500 correct responses in the control group to 4.2727 of the 
five responses in the experimental group. 
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TABLE IV 
ANALYSIS OF VARIANCE FOR RESPONSES OF PATIENTS RECEIVING 
A CALCIUM CHANNEL BLOCKING MEDICATION 
Source 
Sex 
Intervention 
Sex + 
Intervention 
Error 
Corrected 
Total 
N=31 
DF 
1 
1 
1 
27 
30 
Sum of 
Squares 
1.4294 
7.7824 
2.9824 
10.5000 
26.7097 
Mean 
Square 
1.4294 
7.7824 
2.9824 
0.3888 
F 
Value 
3.68 
20.01 
7.67 
Pr > F 
0.0659 
0.0001 
0.0100 
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TABLE V 
MEAN RESPONSES FROM PATIENTS RECEIVING 
A NITRATE MEDICATION 
Category N Mean 
Correct Responses 
Gender 
Male 26 3.8462 
Female 15 3.6000 
Intervention Status 
Control Group 15 2.7333 
Experiment Group 26 4.3462 
Relationship of Gender 
and Intervention 
Male/Control ll 3.0909 
Male/Experimental 15 4.4000 
Female/Control 4 . l. 7500 
Female/Experimental ll 4.2727 
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Table VI illustrates the analysis of variance of the correct 
responses related to gender and group. A significant difference 
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(p < 0.05) was found between the male and female average correct 
responses. The male group responded to a higher average of correct 
responses than the female group. This average included correct 
responses from the control and experimental groups, then divided by 
gender. The-correct responses from the experimental group were 
found to be significantly higher statistically (p < 0.05), than the 
control group. There was no significant difference (p > 0.05) found 
between the male ana female responses in the control group and the 
male and female responses in the experimental group. 
Table VII demonstrates the average of correct responses between 
male and female patients receiving a diuretic medication. 
The male (N=24) respondents had an average of 3.2083 correct 
responses compared to the female (N=27) 3.2963 responses of the five 
possible responses. The control group (N=30) exhibited a 2.766 
correct response rate compared to the 3.9524 correct response rate 
of the experimental group (N-21). 
The relationship between the male and female correct responses 
in the control group was also examined. Table VII illustrates this 
relationship. The male and female experimental groups increased in 
average number of correct responses. The male data increased from a 
2.5714 (N=l4) correct responses in the control group to 4.100 (N=lO) 
correct responses in the experimental group. The female data 
displays an increase from 2.9375 (N=l6) correct responses to a 
3.8182 (N=ll) correct responses in the experimental group. The 
TABLE VI 
ANALYSIS OF VARIANCE FOR RESPONSES OF PATIENTS 
RECEIVING A NITRATE MEDICATION 
Source DF Sum of Mean F 
Squares Square Value 
Sex 1 4.3242 4.3242 4.27 
Intervention 1 29.4549 29.4549 29.11 
Sex + 
Intervention 1 2.9548 2.9548 2.92 
Error 37 37.4409 1. 0119 
Corrected Total 40 67.5610 
N=41 
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Pr > F 
0.0458 
0.0001 
0.0959 
TABLE VII 
MEAN RESPONSES FROM PATIENTS RECEIVING 
DIURETIC MEDICATIONS 
Category N Mean 
Correct Responses 
Gender 
Male 24 3.2083 
Female 27 3.2963 
Intervention Status 
Control Group 30 2.7666 
Experiment Group 21 3.9524 
Relationship of Gender 
and Intervention 
Male/Control 14 2.5714 
Male/Experimental 10 4.1000 
Female/Control 16 2.9375 
Female/Experimental 11 3.8181 
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increase in mean correct responses between the female groups in the 
control and experimental groups the male control and experimental 
groups are exhibited in Figure 4. 
Table VIII displays the analysis of variance for the correct 
responses among patients receiving diuretic medications. There was 
no significant difference (p > 0.05) between the male and female 
correct responses. A significant difference (p <0.05) was present 
between the control and experimental groups. The differences in 
correct responses between the male and females in the control group 
and the males and females in the experimental groups were not found 
to be significant (p > 0.05). 
Summary 
The findings for the study of patients' knowledge regarding 
medication regimen with and without specific educational information 
provided indicated that the educational process played a major role 
in questionnaire response change. Each of the four categories 
adrenergic blocking, calcium channel blocking, diuretic, and nitrate 
medications were examined for the role of the educational program. 
The educational program played a significant role in the 
increase of correct responses from those patients receiving cardiac 
medications followed in the study. This result was observed in all 
categories with a significant level of p=O.OOOl. 
The female population receiving adrenergic blocking agents 
responded at a significantly higher number of correct responses, 
than the male population. The male population receiving nitrate 
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TABLE VIII 
ANALYSIS OF VARIANCE FOR RESPONSES FOR PATIENTS 
RECEIVING A DIURETIC MEDICATION 
Source DF Sum of Mean F 
Squares Square Value 
Sex 1 0.0219 0.0219 0.03 
Intervention 1 17.8689 17.8689 22.16 
Sex + 
Intervention 1 1.2922 1. 2922 1.65 
Error 47 36.9024 0.7852 
Corrected Total 50 35.6863 
N=Sl 
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Pr > F 
0.8682 
0.0001 
0.2058 
medications responded to a significantly higher number of correct 
responses than the female population. These were the only two 
populations with any significant differences among the genders. 
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The educational programs effect upon correct responses among 
gender groups was significantly observed only in the calcium channel 
blocking population. This difference was observed from the female 
population increase of 1.7 average correct responses compared to the 
0.4 correct response increase of the male population. 
The study concluded that the educational program impacted 
several aspects of the study. Several groups displayed a 
significant change at the 0.05 level of significance. The study 
indicates that the educational intervention was the variable that 
increased the number of correct results. 
CHAPTER V 
SUMMARY, CONCLUSIONS, AND RECOMMENDATIONS, 
The purpose of this study was to determine the patients' 
knowledge of their cardiac medication regime with and without 
specific educational information provided. This chapter presents 
the summary, conclusions, and recommendations of this study. 
Summary 
In order to determine the impact of the educational program 
provided, it was necessary to determine the differences that existed 
in the patients that did and did not receive an individualized 
medication educational component. This was done by investigating 
the responses of patients receiving cardiac medications with and 
without an individualized medication educational component. 
A literature search was conducted that included the role of 
cardiac rehabilitation programs and the nurse educators. The review 
focused upon the four following areas: (1) history of cardiac 
rehabilitation programs, (2) role of cardiac medications, (3) role 
of the nurse educator, and (4) review of related research. 
The population of this study was defined as those Stillwater 
Medical Center patients receiving one or more of the following 
cardiac medications: Apresoline, Capoten, Nitroglycerin, 
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Bumex, Lasix, Calan, Cardizem, Tenornun, Catapres, Inderal, 
Lopressor, and Lanoxin. The patients and care givers were assumed 
to have the cognitive learning ability to assimulate new information 
and the dexiterity for performance of technical skills. Patients 
that were being discharged to another hospital facility or nursing 
home were excluded from this study. 
A control group was necessary in order to have a baseline for 
comparison of results. The control group was administered the 
questionnaire pertaining to their medication without variance from 
routine hospital education and discharge procedures: The 
experimental group was ,exposed to an additional individualized 
education program regarding their prescribed specific cardiac 
medication. This information was additional to the routine education 
and discharge program of the hospital patients. 
A summary of the findings indicated that the educational 
program resulted in a significant increase of survey correct 
responses from patients upon discharge than the routine process. 
Conclusions 
There are several implications resulting ,from this study. 
1. Patients can be discharged with increased knowledge of 
their medications. 
2. By using an educational program that explains the 
medications on an individualized basis, possible lethal side effects 
may be avoided. 
3. By increasing the knowledge of the patient regarding 
medications, it may increase patient satisfaction regarding care 
received. 
4. By increasing the knowledge of the patient regarding 
medications, it may increase patient compliance with medication 
regime. 
5. This system can be utilized as a continuous quality 
assurance tool as well as a measurement of patients' knowledge. 
6. The individualized educational program can affect not 
only the hospital personnel but personnel in any health care 
setting. 
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The results of this study demonstrate that the patient 
knowledge with individualized educational programs are superior to 
the routine procedures. The patients had the ability to utilize one 
person as a resource, and ask questions in a casual atmosphere. 
Recommendations 
This study demonstrated that the individualized educational 
component results in an increased awareness of the cardiac 
medication. The following are recommendations made regarding the 
study: 
1. That Stillwater Medical Center continue provisions of 
medication information sheet to those patients receiving a specific 
cardiac medication. 
2. That some type of individualized educational program for 
cardiac patients should be utilized. 
3. That similar studies be completed in other hospitals of 
the same size in various geographical locations. 
4. That similar studies be completed in various health care 
organizations that provide care for cardiac patients. 
5. That additional biases be identified and studied. 
6. That continued investigations and study be made of all 
patient educational programs so that on going-improvements can be 
incorporated into the educational system. 
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APPENDIX A 
COVER LETTER 
so 
STILLWATER 
MEDICAL CENTER 
Stillwater Medical Center Patron, 
At Stillwater Medical Center, we are constantly trying to improve our care to you. As the Director of Patient Care , Services at Stillwater Medical Center, I am asking for your input 
regarding the discharge teaching process specifically addressing knowledge of medications. 
Please assist the staff by completing the questionnaire to the best of your ability. If you are discharged from the hospital prior to receiving the questionaire, a telephone survey 
will be done. This information will aid the staff at Stillwater Medical Center in identifying the effectiveness of our medication discharge program. 
Sincerely, 
(?~'I-.--
Pat Lawson RN 
Stillwater Medical Center 
Director of Patient Care Services 
I understand that participation is voluntary, that there 1~ no penalty for refusal to participate, and the I am free to w1tndraw 
my consent and participation in this project at any time witnou~ penalty after notifying the project director. 
I may contact Cathy Mueggenborg at telephone numDer (405l 743-9704 should I wish further information aoout tne researcr.. I may 
also contact Terry Maciula. universltY Researcn Serv1ce~. 001 Life Sciences East, Oklahoma State Universl~Y. St1llwa~er, 0~ 74078; Telepnone: (405) 744-5700. 
I have read and fully unders~and the consent form. I si9n i~ freely and voluntarily. A copy has been given to me. 
Date __________________________ ___ 
T1me-------------------------
Sisned ______ ~----------~~~--~----------------------------(Slgnature of SubJect) 
I have personally exclained all elements cf th1s form to the patlen~s or care g1vers before r~auest1n9 the ~a~~ent or car~ 9ivers to sign it. 
£igned e~;~at#.e~~1r"1J!r J 
STILLWATER MEDICAL CENTER • BOX 2408 •1323 WEST SIXTH • STILLWATER, OKLAHOMA 74076 • 405-372·1480 
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Please complete this survey form regarding your heart 
medications started during this hospitalization. 
1. What is your sex 
( ) Male ( ) Female 
2. Please check your age range 
( ) Under 40 years of'age ( ) 40 - 50 years of age ( ) 51 - 60 years of age ( ) 61 - 70 years of age ( ) 71 + years of age 
3. This medicine works on the cell level to speed up my heart rate. 
( ) AGREE ( ) DISAGREE 
4. I need to take my pulse before each dose and if it below 100, I skip the dose. 
( ) AGREE ( ) DISAGREE 
5. I need to take this medicine exactly as prescribed. 
( ) AGREE ( ) DISAGREE 
6. I is safe for me to continue my current exercise program. 
( ) AGREE ( ) DISAGREE 
7. This medicine needs to be taken at regular timed intervals. ie every 8 hours or every 12 hours. 
( ) AGREE ( ) DISAGREE 
is 
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Please complete this survey form regarding your heart 
medications started during this hospitalization. 
1. What is your sex 
( ) Male ( ) Female 
2. Please check your age range 
( ) Under 40 years of age 
( ) 40 - 50 years of age 
( ) 51 - 60 years of age 
( ) 61 - 70 years of age 
( ) 71 + years of age 
3. I can change positions as I always have without 
alteration in speed. (sitting to standing position) 
( ) AGREE ( ) -DISAGREE 
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4. If I change my current exercise routine, I need to first 
discuss it with my physician. 
( ) AGREE ( ) DISAGREE 
5. I need to take my pulse rate prior to each dose of 
medicine 
( ) AGREE ( ) DISAGREE 
6. If I'm on a trip and loose this medication, it is safe 
to wait until I speak with my own physician and not take any 
medicine up to 5 days. 
( ) AGREE ( ) DISAGREE 
7. It does not matter what time of day or relationship ~o 
meals when I take this medicine. 
( ) AGREE ( ) DISAGREE 
8. This medicine is effective in lowering my blood pressure 
by decreasing the hearts' contraction. 
( ) AGREE ( ) DISAGREE 
Please complete this survey form regarding your heart 
medications started during this hospitalization. 
1. What is your sex 
( ) Male ( ) Female 
2. Please check your age range 
( ) Under 40 years of age ( ) 40 - 50 years of age ( ) 51 - 60 years of age 
( ) 61 - 70 years of age 
( ) 71 + years of age 
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3. I take this medicine to keep the necessary fluids in my body. 
( ) AGREE ( ) DISAGREE 
4. This medicine works through my kidney. 
( ) AGREE ( ) DISAGREE 
5. There are no sodium (salt) restrictions on my diet with 
this medication. 
( ) AGREE ( ) DISAGREE 
6. I do not need to monitor my excreted fluids in 
relationship to fluids drank. 
( ) AGREE ( ) DISAGREE 
7. It is best to take this medicine in the morning hours. 
( ) AGREE ( ) DISAGREE 
Please complete this survey form regarding your heart 
medications started during this hospitalization. 
1. What is your sex ( ) Male ( ) Female 
2. Please check your age range 
( ) Under 40 years of age ( ) 40 - 50 years of age ( ) 51 - 60 years of age ( ) 61 - 70 years of age ( ) 71 + years of age 
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3. It I have some swelling, it is not normal because this 
medicine will decrease swelling. 
( ) AGREE ( ) DISAGREE 
4. My salt (sodium) intake will not disturb the effect of this medicine. 
( ) AGREE ( ) DISAGREE 
5. This medication if for my blood pressure. 
( ) AGREE ( ) DISAGREE 
6. This medicine is effective because it relaxes (dilates) blood vessels. 
( ) AGREE ( ) DISAGREE 
7. Because of this medicine, I need to change positions 
slower than before. 
( ) AGREE ( ) DISAGREE 
APPENDIX C 
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STILLWATER 
MEDICAL CENTER 
Tenornum (Atenolol) 
Used in the management of hypertension (High Blood Pressure). 
May also be used in treatment of stable angina pectoris. 
Action -
Tenornum selectively blocks the beta-adrenergic receptor in 
the heart muscle. This reduces the diastolic blood pressure. 
Recommendations -
1. Take your pulse prior to taking medication. If pulse 
rate below 60 beats per minute. notify physician before taking 
medication. 
2. Take medications as prescribed by physician. 
3. May be dizzy with sudden position changes. 
upright positions slowly. 
Move into 
4. Notify physician prior to initiation of exercise 
program. 
5. Prior to any surgical procedure, notify your physician 
that you are taking this medication. 
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STILLWATER 
MEDICAL CENTER 
Apresoline (Hydralazine Hydrochloride) 
Used most commonly in 
blood pressure). 
failure. 
Action -
treatment of moderate hypertension (high 
Also used in treatment of congestive heart 
This medication decreases the blood pressure by direct 
relaxation of the vascular smooth muscles. 
Recommendations -
1. Notify physician if renal failure is present. 
2. Consult physician regarding dietary management i.e. salt 
intake. 
3. Monitor your weight and check for swelling in the legs 
and hands. Notify physician of sudden weight gain, slow increase 
in weight, or onset of swelling. 
4. Make position changes slowly, especially from lying to 
standing position. 
5. Avoid standing still for long periods of time, taking 
hot baths/showers, and strenuous exercise. 
6. Avoid excessive alcohol intake. 
7. Do not stop taking medications suddenly. 
8. Keep appointments with physician for follow-up of this 
medication. 
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Bumex 
STILLWATER 
MEDICAL CENTER 
Used for edema associated with congestive heart failure and high 
blood pressure. 
Action -
Stimulates the kidney to excrete excess fluid 
from the body. 
Recommendations -
and sodium 
1. Take medication in early morning to prevent sleep 
disturbances. If ordered twice daily, take second dose in early 
afternoon. 
2. Monitor urine output in relationship to fluid intake. 
3. Notify physician if the following symptoms appear: 
weakness, dizziness, fatigue,faintness, confusion, muscle cramps, 
headache, or new hearing difficulty occurs. 
4. Keep appointments with physician for medication follow-
up. 
5. Adhere to Sodium (salt) restrictions. 
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STILLWATER 
MEDICAL CENTER 
Calan (Verapami1 Hydrochloride, Isoptin) 
Used in the treatment of supraventricular tachyarrhythmias and temporary control of heart rate with atrial dsyrhythmias. Also used to relive exercise induced angina. 
Action -
This medication inhibits the calcium exchange within the 
cardiac cell and this slows electrical impulse conduction througn the heart. This is the mechanism that slows the heart rate down. Another effect of this medicine is the relaxation of the coronary artery wall which increases blood supply and may assist to reduce 
angina discomfort. 
Recommendations -
1. Take your pulse prior to each dose of medication, if the pulse rate is less than 50 beats per minute or the heart beat is irregular, notify your physician prior to taking your medication. 
2. Adhere to your established guidelines for exercise program. 
3. Decrease caffeine containing beverages 
4. Change positions slowly. 
5. Take medications exactly as prescribed by physician. Do Not Alter The Medication Dose Or Change The Frequency Of The Medication. 
6. If anginal pain is not reduced while taking this 
medication, notify your physician. 
7. Keep appointments with physician for periodic evaluation of efficacy of medicine and cardiac status. 
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STILLWATER 
MEDICAL CENTER 
Capoten (Captopril) 
Used in treatment of mild to moderate high blood pressure and 
congestive heart failure. 
Action -
Inhibits the ACE enzyme 
which causes the blood vessels 
blood pressure. 
Recommendations -
(Angiotensin-converting enzyme) 
to relax and thus decreases the 
1. Adhere to sodium restrictions. 
2. Notify physician if unexplained fever, unusual fatigue, 
sore mouth or throat, easy bruising or bleeding occurs. 
3. Mild skin irritations may occur during initial phase of 
medication, notify physician. 
4. Mild cough may be experienced. 
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STILLWATER 
MEDICAL CENTER 
Cardizem (Diltiazem) 
Used in management of coronary artery spasm and angina. 
Action -
Coronary artery dilation (relaxation) occurs to relieve 
angina. Other blood vessels are also increased which decreases 
the resistance the heart must pump against. 
Recommendations -
1. Take medications at time of meals if possible. 
2. Notify physician of any problems. 
3. Take your pulse prior to each dose of medicine, if the 
pulse rate is less than 50 beats per minute or is irregular, 
notify your physician prior to taking your medication. 
4. Take medications exactly as prescribed by physician. Do 
Not Alter The Medication Dose or Change the Frecuency of the 
Medication. 
5. Adhere to your established guidelines for exercise 
program. 
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STILLWATER 
MEDICAL CENTER 
64 
Catapres (Clonidine Hydrochloride) 
Used in treatment of hypertension by itself or in conjunction 
with another medication. 
Action -
Stimulates the Central Nervous System in a manner that 
results in a reduction of blood pressure and heart rate. 
Recommendations -
l. Make position changes slowly from lying to upright 
positions especially. 
2. Keep physician follow-up appointments for medication 
follow-up. 
3. Operate large equipment carefully and with caution. 
This medication may make you drowsy. 
4. Medication must be stopped slowly. ~brupt withdrawal, 
particularly after long-term therapy, may result in complications 
and dramatic increases in blood pressure. 
5. Take medication exactly as prescribed by physician. Do 
not add doses or skip doses of medication. 
6. Do not take over the counter medications without prior 
approval from physician. 
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STILLWATER 
MEDICAL CENTER 
Inderal (Propranolol Hydrochloride) 
65 
Used in management of cardiac arrhythmias, myocardial infarction, angina, and high blood pressure. 
Action -
Inderal works on the heart to decrease the heart rate, myocardial irritability, and the force of contraction. 
Recommendations -
1. Take medication prior to meals if possible. 
2. Take pulse rate prior to 
irregularity noted or heart 
physician, notify physician. 
each dose of medication and if 
outside parameters given by 
3. Prior to initiation of exercise program, notify physician. 
4. Do not abruptly discontinue medication. Take as prescribed by physician. 
5. Prior to any surgical procedures, notify your phys1cian that you are taking this medication. 
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Lanoxin (Digoxin) 
STILLWATER 
MEDICAL CENTER 
66 
Used for maintenance therapy in congestive heart failure, atrial 
fibrillation and atrial flutter. 
Action -
Lanoxin 
the force of 
heart. 
works primarily on the heart muscle by increasing 
contraction and slowing electrical conduction in the 
Recommendations -
1. Check pulse rate prior to administration ana if heart 
rate below 60 beats per minute, notify physician prior to taking 
dose of medication. 
2. If you sense skipped beats or other changes in rhythm, 
notify physician. 
3. Weight yourself daily and if a weight gain of 2 pounds 
or more noted in a day, notify physician. 
4. Reduce salt intake by omitting salty foods. 
5. Take medication exactly as prescribed-do not take extra 
doses or skip doses. 
6. Keep this medication out of reach from children. 
7. Notify physician prior to administration of any other 
over the counter medications. 
8. Visit with physician prior to initiation of exercise 
program. 
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Lasix (Furosemide) 
STILLWATER 
MEDICAL CENTER· 
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Used in treatment of edema (swelling) associated with congestive 
heart failure, liver disease, renal disease, & hypertension 
(high blood pressure). 
Action -
Rapid acting medication within the kidney to excrete excess 
fluids in the body. 
Recommendations -
1. To prevent sleep disturbance, take medication in the 
morning if ordered once per day. Take medication in morning and 
early afternoon if ordered twice per day. 
2. Observe urine output to ensure that the excess fluid is 
being excreted. 
3. If you experience anything out of the ordinary, notify 
your physician. 
4. Adhere to sodium (salt) restriction. 
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STILLWATER 
MEDICAL CENTER 
Lopressor (Betaloc, Metoprolol Tartrate) 
Used in management of mild to severe hypertension. 
Action -
68 
Lopressor selectively blocks the beta-adrenergic receptor 
which results in lowering the blood pressure. 
Recommendations -
1. Due to problems with absorption 
needs to be taken with food with every 
stomach with every dose. 
of this medication, it 
dose, or upon an empty 
2. Take your heart rate prior to each dose, if the rate is 
below 50 beats per minute or irregular, notify physician prior to 
taking your medication. 
3. Take medication as prescribed by physician. 
4. Do not stop taking medication. The medication must 
slowly be decreased in dosage prior to its' discontinuation. 
5. Notify physician of plans for exercise program prior to 
beginning program. 
6. Prior to any surgical procedure, notify your physician 
that you are taking this medication. 
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MEDICAL CENTER 
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Nitroglycerin (Tridil, Nitrostat. Nitro-Our, NTG, Transderm-
Nitro. Isosorbide Dinitritate) 
Used in the prevention and treatment of angina pain. 
Action -
Most prominent effect of medication is upon the blood 
vessels and decreases the resistance within the vessels that the 
heart pumps against. 
Recommendations -
1. Sit or lie down at first indication of anginal pain. 
Place tablet under tongue while laying down. 
2. Relax 15-20 minutes after taking medication. 
3. If anginal pain is not relieved after 1 nitroglycerin. 
take a second tablet 5 minutes after the original tablet. If 
pain remains unrelieved in 5 more minutes take a 3rd tablet under 
the tongue. If anginal pain remains after 3rd tablet, have 
someone take you directly to the emergency room. 
4. If possible, retain a record of anginal attacks along 
with precipitating factors, duration, and frequency of pain. 
5. Inform family members of location of NTG bottle. 
6. Note expiration date of side of label, medication can 
expire. Discard bottles opened 6 months ago or longer. 
7. Notify physician if angina attacks appear to be 
increasing in frequency and duration. 
8. Carry medical identification card informing health care 
workers that you are taking this medication. 
9. Adhere to sodium (salt) restrictions. 
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I. 
II. 
71 
Day I 
A. Introduction 
a. Introduction of study 
b. Introduction of researcher 
B. Acquire consent for participation 
c. Provide medication information sheet 
a. Briefly review the medication names 
b. Briefly review the uses for the medication 
c. Briefly review the action of the medication 
d. Briefly review the recommendations 
l. Beging teaching skill if indicated 
D. Assess current level of understanding regarding 
medications 
Day II 
A. Invite questions and/or concerns to be verbalized 
B. Cover the information sheet in detail. Acknowledge 
information understood by patient or care giver 
C. Teach skills necessary for compliance with recommendations 
a. Teach technique for calculation of heart rate per 
minute. This technique is required for those patients 
receiving the followign medications: Cardizem, 
Inderal, Lanoxin, Lopressor, and Tenormun. 
b. Provide information for measuring of fluids drank in 
relation to fluids excreted. This technique is 
required for those patients receiving the following 
medications: Bumex and Lasix. 
c. Demonstrate with a return demonstration regarding 
position changes. Changing position from lying to 
standing position. This technique is required for 
those patients receiving the following medications: 
Calan, Catapres, Nigroglycerin, and Tenornum. 
d. Display poster for chest pain interventions land 
administration of nitroglycerin. Patient will 
verbally state sequence of interventions 
appropriately. 
III. Day III to Discharge 
A. Invite questions and/or concerns to be verbalized 
B. Review information that patient/care giver understand 
c. Review skills for accuracy of techniques 
D. Continue to provide detailed instructions, regarding the 
information that the patient and/or care giver may be 
questionning. 
72 
IV. Discharge 
A. Invite questions and/or concerns to be verbalized 
B. Request patient or care giver to complete survey 
c. Provide appreciation toward the patient and/or care giver 
for the participation in the study. 
!!! CHEST PAIN !!! 
What Do I Do? 
Discomfort in Chest 
Lie down and take 
l NTG under 
tongue 
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Relief 5 minutes Discomfort 
~ ----- later ------ remains ~ 
Remain lying down 
for 15-20 minutes 
Discomfort 5 minutes 
~ relieved ----- later 
Remain lying down 
for 15-20 minutes 
I 
Write incident 
in journal 
Place l NTG 
under tongue 
I 
Pain 
remains 
I 
Place l NTG 
under tongue 
Relief 5 minutes Chest 
of pain _____ later discomfort I -
1 
remains 
Remain lying down 
for 15-20 minutes 
Call 911 
& seek medical 
attention 
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